Huolun Feng

7PUBLICATIONS
34CO-AUTHORS
Disease surveillancePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Targeting DOT1L Reactivates HERV-K to Drive Cell-Autonomous and Paracrine Senescence in Adenocarcinoma of the Esophagogastric Junction.

|Jan 26, 2026
Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response.

Huolun Feng, Kunling Chen, Zhihui Xi

|Sep 12, 2025
Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity.

Fan Xing, Xuemei Wang, Zeying Li

|Aug 12, 2025
Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma.

Kunling Chen, Huolun Feng, Yujie Zhang

|Jan 13, 2025
Clonal Hematopoiesis of Indeterminate Potential as a Predictor of Colorectal Cancer Risk: Insights from the UK Biobank Cohort.

Yongfeng Liu, Zhihui Xi, Jianlong Zhou

|Dec 05, 2024
LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis.

Huolun Feng, Wei Yao, Yucheng Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Yong Li

3 joint publications

Jiabin Zheng

3 joint publications

Zhihui Xi

3 joint publications

Fan Xing